Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Emcure Pharmaceuticals Ltd
EMCURE | NSE
1,756.80
INR11.60
0.66%
EMCURE | NSE
Loading StockChartView...
About Emcure Pharmaceuticals Ltd
Sector
IN
Industry
IN
Earnings date
01/01/1970
As of date
05/06/2026
Close
1,756.80
Open
1,760.00
High
1,796.70
Low
1,746.00
View Less
EMCURE | NSE
Risk
23.5
Sharpe
0.79
Luna's Score
57/100
Recommendation
Hold
Luna says (EMCURE | NSE)
What's Working
Positive Momentum
Strong Revenue Growth (> 10%)
What's not Working
Midcap (2B - 10B USD)
Rich in Valuation (Price to Book > 8)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
26.5%1 month
23.5%3 months
42.5%6 months
36.0%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
54.29
Fwd. PE
-
Price to book
9.39
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
22.49
Ent. to rev.
4.66
PEG
-
Other Fundamentals
EBITDA
12.05B
MarketCap
318.73B
MarketCap(USD)
3.36B
Div. yield
-
Op. margin
13.37
Erngs. growth
10.30
Rev. growth
16.60
Ret. on equity
-
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
129.70
Range1M
169.30
Range3M
435.10
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.70
Price X volume
206.29M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 22.49 | 38.27 | Cheaper |
| Ent. to Revenue | 4.66 | 10.34 | Cheaper |
| PE Ratio | 54.29 | 60.68 | Par |
| Price to Book | 9.39 | 9.15 | Par |
| Dividend Yield | - | 0.66 | - |
| Std. Deviation (3M) | 42.50 | 43.73 | Par |
| Debt to Equity | - | 0.59 | - |
| Debt to Assets | - | 0.20 | - |
| Market Cap | 318.73B | 104.65B | Market Leader |
